Denosumab in the treatment of delayed hypercalcemia after rhabdomyolysis

Nabil W.G. Sweis, Ahmed Noor, Karen Jong, Joseph L. Zapater

Open source

DOI
10.1016/j.jecr.2025.100193
Published
2025-09
Container
Journal of Clinical and Translational Endocrinology: Case Reports
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jecr.2025.100193,
  title = {Denosumab in the treatment of delayed hypercalcemia after rhabdomyolysis},
  author = {Nabil W.G. Sweis and Ahmed Noor and Karen Jong and Joseph L. Zapater},
  year = {2025},
  journal = {Journal of Clinical and Translational Endocrinology: Case Reports},
  doi = {10.1016/j.jecr.2025.100193},
  url = {https://doi.org/10.1016/j.jecr.2025.100193}
}

RIS

TY  - JOUR
TI  - Denosumab in the treatment of delayed hypercalcemia after rhabdomyolysis
AU  - Nabil W.G. Sweis
AU  - Ahmed Noor
AU  - Karen Jong
AU  - Joseph L. Zapater
PY  - 2025
JO  - Journal of Clinical and Translational Endocrinology: Case Reports
DO  - 10.1016/j.jecr.2025.100193
UR  - https://doi.org/10.1016/j.jecr.2025.100193
ER  - 

APA

Sweis, N. W., Noor, A., Jong, K., & Zapater, J. L. (2025). Denosumab in the treatment of delayed hypercalcemia after rhabdomyolysis. Journal of Clinical and Translational Endocrinology: Case Reports. https://doi.org/10.1016/j.jecr.2025.100193

Source records